相似文献/References:
[1]廖晓玲,李进亮,郑丽红.拓宽渠道 推进医改——对福建永定基层医改的思考[J].卫生经济研究,2016,(09):20.
[2]郭孟子,李紫航,陈艺璇,等.“三医”协同视角下国谈药“双通道”高质量发展研究[J].卫生经济研究,2024,41(08):4.
GUO Mengzi,LI Zihang,CHEN Yixuan,et al.Study on the High-quality Development of the "Dual channel"
of National Negotiated Drugs from the Perspective of "Three Medical" Synergy[J].Journal Press of Health Economics Research,2024,41(01):4.
[3]王 琪,杜启霞,乔学斌,等.整体智治视角下数字化赋能“三医”协同发展和治理研究 ——基于南京“医保高铁”案例分析[J].卫生经济研究,2026,43(02):21.
WANG Qi,DU Qixia,QIAO Xuebin,et al.Study on the Digital Empowerment for the Coordinated Development and Governance of Medical Services, Medical Securityand Pharmaceutical Industry from the Perspective of Holistic Intelligent Governance——Based on a Case Study of Nanjing’s "Medical Insurance High-Speed Railway"[J].Journal Press of Health Economics Research,2026,43(01):21.
[4]吴 珍,陈星宇,胡琳琳.药品领域“三医”协同治理困境与优化路径研究[J].卫生经济研究,2026,43(04):1.
WU Zhen,CHEN Xingyu,HU Linlin.Collaborative Governance Dilemmas and Optimization Strategies for "Three Medicals" Synergy in the Pharmaceutical Sector[J].Journal Press of Health Economics Research,2026,43(01):1.
[5]马振涛,文晓初,郎 堃.“三医”协同体系下商业健康险支持创新药发展:模式、问题与建议[J].卫生经济研究,2026,43(04):25.
MA Zhentao,WEN Xiaochu,LANG Kun.Commercial Health Insurance Supporting Innovative Drug Development under the "Three Medical" Collaborative System: Models, Issues and Recommendations[J].Journal Press of Health Economics Research,2026,43(01):25.
[6]付超奇.医保影像云的核心逻辑、建设思路及价值前景[J].卫生经济研究,2026,43(07):5.
FU Chaoqi.Core Logic, Development Approach, and Value Prospects of the Cloud-Based Medical Imaging Management System for Healthcare Security[J].Journal Press of Health Economics Research,2026,43(01):5.